Precursor T-cell acute lymphoblastic leukemia
MONDO:0020512Also known as: T-ALL, precursor T-cell acute lymphoblastic leukemia/lymphoma, precursor T-cell acute lymphocytic leukaemia, precursor T-cell acute lymphocytic leukemia, precursor T-cell acute lymphocytic leukemia/lymphoma
1945 clinical trials for this condition and its sub-types, 4 tagged with Precursor T-cell acute lymphoblastic leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New antibody combo tackles tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug isatuximab to standard chemotherapy can help adults with T-cell acute lymphoblastic leukemia (T-ALL) that has relapsed or not responded to treatment. The study enrolls 40 people in two groups: one for those with a full relapse…
Phase 2 • Sponsor: Goethe University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood leukemia in new trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD123-CAR T cells for children and young adults (up to age 21) with certain types of leukemia or related blood cancers that have come back or not responded to standard therapy. The treatment involves collecting the patient's own…
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New CAR-T therapy targets tough T-Cell cancers in early trial
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy that targets a protein called CD5 on cancer cells. It is for people with T-cell acute lymphoblastic leukemia or T-cell lymphoma that has come back or not responded to treatment. The trial has two phases: first, finding the safest …
Phase 1/2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC